Regarding OCLs, myeloma cells trigger a coordinated upregulation in RANKL and decrease in OPG expression by BM MSCs and OBLs leading to an increased OCL differentiation and activity in patients (49–52). Here, TNFSF11 is linked to plasma cell myeloma.